Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Exp Obstet Gynecol ; 43(3): 358-64, 2016.
Article in English | MEDLINE | ID: mdl-27328491

ABSTRACT

BACKGROUND: Cisplatin is an important chemotherapeutic agent that is widely used in treatment of several malignancies, but its side effects on normal tissues and organs limit its use. The aim of this study was to evaluate the effect of aqueous extract of sweet fennel alone and in combination with cisplatin on human cervical cancer adenocarcinoma cell line (HeLa cells) searching for an effective, inexpensive therapy with minimal side effects. MATERIALS AND METHODS: HeLa cell line was used to study the cytotoxic effect of different concentrations of the aqueous extract of sweet fennel alone and in combination with 50 µg/ml cisplatin. Quantitative measure of drug interaction was quantified by the combination index. Gas chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC) were used to analyze the sweet fennel decoction. MTT assay was used to examine cell viability percentage. Electron microscopy was applied to study the ultrastructure of the cells. RESULTS: The phenyl propanoids (23%) and phenols (12%) constituted the highest percentage of the aqueous extract. Increasing the concentration of sweet fennel from 50 µg/ml to 80 µg/ml, decreased the percentage of the cell viability of HeLa cells from 86.74% to 78.28%, respectively. Further decrease to 11.31% was demonstrated when 50 µg/ml of fennel was combined with 50 µg/ml cisplatin (additive effect). In addition to the signs of apoptosis observed in HeLa cells at 50 µg/ml of fennel, disruption of both nuclear and cytoplasmic membranes and presence of autophagolysosomes were noticed at a dose of 80 µg/ml. Combination of 50 µg/ml of cisplatin with 60, 70, and 80 µg/ml of sweet fennel revealed no significant difference in comparison to cisplatin alone. The combination with 50 µg/ml of sweet fennel revealed marked vacuolization of the cytoplasm, fragmentation of the nucleus, and complete disruption of nuclear membrane. CONCLUSIOn: Combination of cisplatin and the 50 µg/ml of the fennel could enhance cervical cancer growth inhibition. This combination could be effective in lowering the dose of single or repeated cumulative courses of cisplatin and hence decreases its hazardous side effects. In vivo studies and the evaluation of different combination doses of cisplatin and sweet fennel are recommended.


Subject(s)
Adenocarcinoma , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Autophagy/drug effects , Chromatin/drug effects , Cisplatin/pharmacology , Foeniculum , Nuclear Envelope/drug effects , Plant Extracts/pharmacology , Uterine Cervical Neoplasms , Cell Membrane/drug effects , Cell Membrane/ultrastructure , Cell Survival/drug effects , Chromatin/ultrastructure , Chromatography, High Pressure Liquid , Female , Gas Chromatography-Mass Spectrometry , HeLa Cells , Humans , Microscopy, Electron , Nuclear Envelope/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...